🇺🇸 Klonopin in United States

FDA authorised Klonopin on 4 June 1975 · 29,537 US adverse-event reports

Marketing authorisations

FDA — authorised 4 June 1975

  • Application: NDA017533
  • Marketing authorisation holder: CHEPLAPHARM
  • Local brand name: KLONOPIN
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 3,860 reports (13.07%)
  2. Nausea — 3,365 reports (11.39%)
  3. Anxiety — 3,348 reports (11.33%)
  4. Fatigue — 3,342 reports (11.31%)
  5. Headache — 2,895 reports (9.8%)
  6. Depression — 2,842 reports (9.62%)
  7. Insomnia — 2,796 reports (9.47%)
  8. Pain — 2,604 reports (8.82%)
  9. Dizziness — 2,496 reports (8.45%)
  10. Diarrhoea — 1,989 reports (6.73%)

Source database →

Other Neuroscience approved in United States

Frequently asked questions

Is Klonopin approved in United States?

Yes. FDA authorised it on 4 June 1975; FDA has authorised it.

Who is the marketing authorisation holder for Klonopin in United States?

CHEPLAPHARM holds the US marketing authorisation.